IOVA News and Press, Iovance Biotherapeutics Inc. From 12/27/23

2023-12-27 08:36:23 ET Iovance Biotherapeutics (NASDAQ: IOVA) stock price suffered a harsh reversal on Wednesday after the company suffered a major setback. The stock, which has been in a strong uptrend, crashed by more than 30% in the pre-market session. It fell to a low of $6.50, whic...

2023-12-27 08:29:57 ET Losers: Iovance Biotherapeutics ( IOVA ) -24% announces clinical hold on mid-stage trial for lung cancer therapy . Nukkleus ( OTC:NUKK ) -23% . Baosheng Media Group Holdings ( BAOS ) -21% . 60 Degrees Pharmaceuticals ( S...

2023-12-27 07:20:21 ET More on Iovance Biotherapeutics Iovance Biotherapeutics: The Easiest Money May Have Been Made, But Approval Does Seem Likely Iovance Biotherapeutics, Inc. (IOVA) Q3 2023 Earnings Call Transcript Iovance Biotherapeutics: Testing Shareholders' Pa...

SAN CARLOS, Calif., Dec. 27, 2023 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating, developing and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with cancer, today announced a clinical program ...

2023-12-21 09:45:08 ET Marathon Patent Group Inc (MARA) MARA is trading UP for the last 5 days, and it at trading at $23.35 with volume of 30,990,252 and a one day change of $1.25 (5.66%). Marathon Patent Group Inc has a 52-week low of 3.11 and a 52-week high of $20.09. The business...

2023-12-12 13:25:35 ET Summary IOVA's marketing application for lifileucel is still awaiting approval from the FDA, with a new decision date set for February 24, 2024. Despite the delay, IOVA suggests a possible early approval in January 2024. IOVA expects its current cash to ...

2023-11-22 14:22:43 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips In this market cycle that we are experiencing, new opportunities arise to take advantage of over the next few years. There is no better way to take advantage of these opportunities than through...

2023-11-20 12:00:21 ET Shares of Iovance Biotherapeutic s (NASDAQ: IOVA) were jumping 10.9% higher as of 11:49 a.m. ET on Monday. The nice gain came after Goldman Sachs initiated coverage on Iovance stock with a buy recommendation. Investors no doubt liked Goldman Sachs' 12-...

2023-11-20 08:22:56 ET LogicMark  ( LGMK ) +22% . GD Culture Group ( GDC ) +22% Unveils its Transformative and Photorealistic AI-driven Digital Human Technology on TikTok YPF ( YPF ) +19% . Central Puerto ( CEPU ) +17% . Loma Negra ...

2023-11-08 13:03:43 ET On a brutal day for biotech stocks, Iovance Biotherapeutics (NASDAQ: IOVA) is defying the broader trend across the space. Specifically, the adoptive cell therapy company's shares were up by 7.75% on heavy volume as of 11:49 a.m. ET Wednesday. Meanwhile, th...